{"id":11080,"date":"2026-06-22T12:29:53","date_gmt":"2026-06-22T15:29:53","guid":{"rendered":"https:\/\/www.prcardio.org\/profissionais-saude\/?p=11080"},"modified":"2026-06-22T12:29:53","modified_gmt":"2026-06-22T15:29:53","slug":"novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo","status":"publish","type":"post","link":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/","title":{"rendered":"Novo f\u00e1rmaco para obesidade \u00e9 eficaz na redu\u00e7\u00e3o do risco card\u00edaco, aponta estudo"},"content":{"rendered":"\n<p>Um estudo cl\u00ednico recente publicado no peri\u00f3dico cient\u00edfico <em>Annals of Internal Medicine<\/em> consolidou a efic\u00e1cia da Tirzepatida no tratamento do risco cardiovascular em pacientes com sobrepeso e diabetes tipo 2.<br><br>Os dados do estudo, denominado <em>SURPASS-early<\/em>, ganharam destaque no \u00faltimo boletim cient\u00edfico internacional e apontam a superioridade do medicamento em rela\u00e7\u00e3o \u00e0 terapia convencional, que \u00e9 baseada predominantemente no uso da Semaglutida.<\/p>\n\n\n\n<p>Para o cardiologista e diretor de comunica\u00e7\u00e3o da Sociedade Paranaense de Cardiologia, Dr. Jos\u00e9 Knopfholz, o acompanhamento de dois anos dos pacientes revelou uma diferen\u00e7a significativa tanto na perda de peso quanto no controle metab\u00f3lico geral:<br><br><em>&#8220;Os dados indicam que essa classe de medicamentos atua diretamente na melhora do perfil lip\u00eddico e na redu\u00e7\u00e3o do risco cardiovascular geral. A tend\u00eancia \u00e9 que ela se torne central na preven\u00e7\u00e3o de doen\u00e7as card\u00edacas em pacientes com obesidade e dist\u00farbios metab\u00f3licos&#8221;, afirma o cardiologista.<\/em><\/p>\n\n\n\n<p>No estudo, o grupo que utilizou a Tirzepatida apresentou uma perda m\u00e9dia de 13,8 kg, em compara\u00e7\u00e3o com 5,9 kg registrados no grupo da terapia convencional. Al\u00e9m da redu\u00e7\u00e3o do peso corporal, os pacientes que receberam o novo f\u00e1rmaco obtiveram melhoras nos n\u00edveis de triglicer\u00eddeos, na press\u00e3o arterial e na sensibilidade \u00e0 insulina.<\/p>\n\n\n\n<p>Knopfholz explica que o impacto dessas novas classes de medicamentos vai al\u00e9m do fator est\u00e9tico ou do tratamento isolado do diabetes:<\/p>\n\n\n\n<p><em>&#8220;Essas medica\u00e7\u00f5es atuam diretamente na melhora massiva do perfil lip\u00eddico do paciente. Diante dos resultados apresentados, a tend\u00eancia \u00e9 que os medicamentos passem a ser mais indicados na preven\u00e7\u00e3o de doen\u00e7as do cora\u00e7\u00e3o em indiv\u00edduos que convivem com a obesidade e dist\u00farbios metab\u00f3licos&#8221;, afirma o cardiologista.<\/em><\/p>\n\n\n\n<p>Segundo o m\u00e9dico, o estudo refor\u00e7a a mudan\u00e7a de protocolo na cardiologia preventiva, integrando o controle de peso como um dos pilares centrais para reduzir a incid\u00eancia de infartos e outras complica\u00e7\u00f5es cardiovasculares cr\u00f4nicas.<\/p>\n<!--themify_builder_content-->\n<div id=\"themify_builder_content-11080\" data-postid=\"11080\" class=\"themify_builder_content themify_builder_content-11080 themify_builder tf_clear\">\n    <\/div>\n<!--\/themify_builder_content-->\n","protected":false},"excerpt":{"rendered":"<p>Um estudo cl\u00ednico recente publicado no peri\u00f3dico cient\u00edfico Annals of Internal Medicine consolidou a efic\u00e1cia da Tirzepatida no tratamento do risco cardiovascular em pacientes com sobrepeso e diabetes tipo 2. Os dados do estudo, denominado SURPASS-early, ganharam destaque no \u00faltimo boletim cient\u00edfico internacional e apontam a superioridade do medicamento em rela\u00e7\u00e3o \u00e0 terapia convencional, que [&hellip;]<\/p>\n","protected":false},"author":116,"featured_media":11081,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-11080","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SPC - Sociedade Paranaense de Cardiologia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SPC - Sociedade Paranaense de Cardiologia\" \/>\n<meta property=\"og:description\" content=\"Um estudo cl\u00ednico recente publicado no peri\u00f3dico cient\u00edfico Annals of Internal Medicine consolidou a efic\u00e1cia da Tirzepatida no tratamento do risco cardiovascular em pacientes com sobrepeso e diabetes tipo 2. Os dados do estudo, denominado SURPASS-early, ganharam destaque no \u00faltimo boletim cient\u00edfico internacional e apontam a superioridade do medicamento em rela\u00e7\u00e3o \u00e0 terapia convencional, que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/\" \/>\n<meta property=\"og:site_name\" content=\"SPC - Sociedade Paranaense de Cardiologia\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-22T15:29:53+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kakoi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kakoi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/\"},\"author\":{\"name\":\"kakoi\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/3804e39c97cb226a4c7ea1ef988b63e7\"},\"headline\":\"Novo f\u00e1rmaco para obesidade \u00e9 eficaz na redu\u00e7\u00e3o do risco card\u00edaco, aponta estudo\",\"datePublished\":\"2026-06-22T15:29:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/\"},\"wordCount\":346,\"image\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/06\\\/medicamento-coracao.jpg\",\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/\",\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/\",\"name\":\"SPC - Sociedade Paranaense de Cardiologia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/06\\\/medicamento-coracao.jpg\",\"datePublished\":\"2026-06-22T15:29:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/3804e39c97cb226a4c7ea1ef988b63e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/06\\\/medicamento-coracao.jpg\",\"contentUrl\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/06\\\/medicamento-coracao.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo f\u00e1rmaco para obesidade \u00e9 eficaz na redu\u00e7\u00e3o do risco card\u00edaco, aponta estudo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#website\",\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/\",\"name\":\"SPC - Sociedade Paranaense de Cardiologia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/#\\\/schema\\\/person\\\/3804e39c97cb226a4c7ea1ef988b63e7\",\"name\":\"kakoi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g\",\"caption\":\"kakoi\"},\"url\":\"https:\\\/\\\/www.prcardio.org\\\/profissionais-saude\\\/author\\\/kakoi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SPC - Sociedade Paranaense de Cardiologia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/","og_locale":"pt_BR","og_type":"article","og_title":"SPC - Sociedade Paranaense de Cardiologia","og_description":"Um estudo cl\u00ednico recente publicado no peri\u00f3dico cient\u00edfico Annals of Internal Medicine consolidou a efic\u00e1cia da Tirzepatida no tratamento do risco cardiovascular em pacientes com sobrepeso e diabetes tipo 2. Os dados do estudo, denominado SURPASS-early, ganharam destaque no \u00faltimo boletim cient\u00edfico internacional e apontam a superioridade do medicamento em rela\u00e7\u00e3o \u00e0 terapia convencional, que [&hellip;]","og_url":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/","og_site_name":"SPC - Sociedade Paranaense de Cardiologia","article_published_time":"2026-06-22T15:29:53+00:00","og_image":[{"width":1200,"height":800,"url":"http:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg","type":"image\/jpeg"}],"author":"kakoi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"kakoi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#article","isPartOf":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/"},"author":{"name":"kakoi","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/3804e39c97cb226a4c7ea1ef988b63e7"},"headline":"Novo f\u00e1rmaco para obesidade \u00e9 eficaz na redu\u00e7\u00e3o do risco card\u00edaco, aponta estudo","datePublished":"2026-06-22T15:29:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/"},"wordCount":346,"image":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg","articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/","url":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/","name":"SPC - Sociedade Paranaense de Cardiologia","isPartOf":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#primaryimage"},"image":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg","datePublished":"2026-06-22T15:29:53+00:00","author":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/3804e39c97cb226a4c7ea1ef988b63e7"},"breadcrumb":{"@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#primaryimage","url":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg","contentUrl":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-content\/uploads\/sites\/2\/2026\/06\/medicamento-coracao.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/novo-farmaco-para-obesidade-e-eficaz-na-reducao-do-risco-cardiaco-aponta-estudo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.prcardio.org\/profissionais-saude\/"},{"@type":"ListItem","position":2,"name":"Novo f\u00e1rmaco para obesidade \u00e9 eficaz na redu\u00e7\u00e3o do risco card\u00edaco, aponta estudo"}]},{"@type":"WebSite","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#website","url":"https:\/\/www.prcardio.org\/profissionais-saude\/","name":"SPC - Sociedade Paranaense de Cardiologia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.prcardio.org\/profissionais-saude\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/www.prcardio.org\/profissionais-saude\/#\/schema\/person\/3804e39c97cb226a4c7ea1ef988b63e7","name":"kakoi","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9419357d373f9eb94fa7183aa5c7125bbdfd5783cb4628cd0fb257727c5c48e9?s=96&d=mm&r=g","caption":"kakoi"},"url":"https:\/\/www.prcardio.org\/profissionais-saude\/author\/kakoi\/"}]}},"builder_content":"","_links":{"self":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/11080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/users\/116"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/comments?post=11080"}],"version-history":[{"count":2,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/11080\/revisions"}],"predecessor-version":[{"id":11083,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/posts\/11080\/revisions\/11083"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/media\/11081"}],"wp:attachment":[{"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/media?parent=11080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/categories?post=11080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.prcardio.org\/profissionais-saude\/wp-json\/wp\/v2\/tags?post=11080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}